TradingView
AlenCiken
7. Aug. 2018 11:25
final study suports + 55$m financing secured
NASDAQ:PTGX
240
Protagonist Therapeutics, Inc.
NASDAQ
Beschreibung
⋅
7. Aug. 2018 11:25
finviz.com/quote.ashx?t=PTGX&ty=c&p=d&b=1
Trend Analysis
Chart Patterns
Technical Indicators
Mehr